when were glp 1 drugs approved History of glucagon-like peptide-1 receptor agonists GLP-1 Agonists Weight Loss Drugs
Description
Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
J Am Stat Ass
Most GLP-1 receptor agonists are given as a small injection under your skin, typically once a week
If you are planning a pregnancy, youll usually be advised to stop these medicines some time before conception and switch to treatments known to be safe in pregnancy, such as insulin
